StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)

Analysts at StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note issued on Tuesday. The firm set a “hold” rating on the stock.

Separately, Benchmark reaffirmed a “speculative buy” rating and issued a $1.25 price target on shares of Milestone Scientific in a research note on Wednesday, November 20th.

Milestone Scientific Stock Performance

MLSS stock opened at $1.22 on Tuesday. Milestone Scientific has a one year low of $0.54 and a one year high of $1.32. The firm has a market cap of $95.03 million, a PE ratio of -17.43 and a beta of 1.10. The firm’s 50 day moving average price is $0.92 and its 200-day moving average price is $0.91.

Institutional Trading of Milestone Scientific

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Geode Capital Management LLC grew its stake in shares of Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after buying an additional 31,572 shares in the last quarter. Carnegie Investment Counsel grew its position in Milestone Scientific by 18.9% in the 4th quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock valued at $166,000 after acquiring an additional 27,412 shares in the last quarter. World Investment Advisors LLC purchased a new stake in Milestone Scientific during the third quarter worth about $91,000. Finally, Y Intercept Hong Kong Ltd acquired a new stake in shares of Milestone Scientific during the third quarter worth about $48,000. Hedge funds and other institutional investors own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.